Thesis check
- Q3 revenue of $267.83 million beat the $257.18 million consensus, up 73% year over year and 14% from Q2
- revenue landed above the top of management's $250 million to $265 million guidance range
- operating margin had already narrowed to -24.6% in Q2 2026 from -49.5% two years earlier
- shares up double digits on the report despite prediction markets pricing only a 37% chance of a beat
- EPS of -$0.12 missed the -$0.07 estimate, with losses widening as revenue climbs
- Q2 2026 gross margin slipped to 36.1% from 38.2% in Q1, the first step back in two years
- Neutron pad delivery target sits in Q4 2026 with no revenue from the larger vehicle yet
- stock still 25% below its 200-day average going into the report
The 73% revenue jump tips it: cadence is scaling faster than Wall Street modeled, and investors appear willing to fund the losses while that holds. The wider EPS miss is the crack to watch. A second straight quarter of falling gross margin, or any slip in the Q4 Neutron pad timeline, would turn this to weakening.







